178 related articles for article (PubMed ID: 8382096)
1. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M
Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096
[TBL] [Abstract][Full Text] [Related]
2. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
Jansen CL; Maris-Tegeler WG; Wertheim-van Dillen PM; Frissen PH; Weiland HT; van der Noordaa J
Ned Tijdschr Geneeskd; 1992 Feb; 136(6):280-4. PubMed ID: 1311058
[TBL] [Abstract][Full Text] [Related]
3. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome.
Sall RK; Kauffman CL; Levy CS
Arch Dermatol; 1989 Nov; 125(11):1548-50. PubMed ID: 2554819
[TBL] [Abstract][Full Text] [Related]
5. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
Safrin S; Crumpacker C; Chatis P; Davis R; Hafner R; Rush J; Kessler HA; Landry B; Mills J
N Engl J Med; 1991 Aug; 325(8):551-5. PubMed ID: 1649971
[TBL] [Abstract][Full Text] [Related]
6. Antiviral susceptibilities of herpes simplex virus isolates from infants with recurrent mucocutaneous lesions after neonatal infection.
Rabalais GP; Nusinoff-Lehrman S; Arvin AM; Levin MJ
Pediatr Infect Dis J; 1989 Apr; 8(4):221-3. PubMed ID: 2541398
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
Chatis PA; Miller CH; Schrager LE; Crumpacker CS
N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
[No Abstract] [Full Text] [Related]
8. Low-dose oral acyclovir for prevention of herpes simplex virus infection during OKT3 therapy.
Tang IY; Maddux MS; Veremis SA; Bauma WD; Pollak R; Mozes MF
Transplant Proc; 1989 Feb; 21(1 Pt 2):1758-60. PubMed ID: 2652575
[TBL] [Abstract][Full Text] [Related]
9. Severe herpes simplex virus hepatitis following autologous bone marrow transplantation: successful treatment with high dose intravenous acyclovir.
Hayashi M; Takeyama K; Takayama J; Ohira M; Tobinai K; Shimoyama M
Jpn J Clin Oncol; 1991 Oct; 21(5):372-6. PubMed ID: 1753418
[TBL] [Abstract][Full Text] [Related]
10. Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data.
Safrin S; Assaykeen T; Follansbee S; Mills J
J Infect Dis; 1990 Jun; 161(6):1078-84. PubMed ID: 2161035
[TBL] [Abstract][Full Text] [Related]
11. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial.
Hardy WD
Am J Med; 1992 Feb; 92(2A):30S-35S. PubMed ID: 1531285
[TBL] [Abstract][Full Text] [Related]
12. Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation.
Ljungman P; Ellis MN; Hackman RC; Shepp DH; Meyers JD
J Infect Dis; 1990 Jul; 162(1):244-8. PubMed ID: 2162368
[TBL] [Abstract][Full Text] [Related]
13. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
Erlich KS; Jacobson MA; Koehler JE; Follansbee SE; Drennan DP; Gooze L; Safrin S; Mills J
Ann Intern Med; 1989 May; 110(9):710-3. PubMed ID: 2522751
[TBL] [Abstract][Full Text] [Related]
14. [Chronic erosive, therapy-resistant perianal herpes (type II) with herpes proctitis in AIDS].
Bratzke B; Orfanos CE; Stavermann T; Ehlers G
Hautarzt; 1991 Feb; 42(2):96-100. PubMed ID: 1828066
[TBL] [Abstract][Full Text] [Related]
15. Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro.
Ljungman P; Wilczek H; Gahrton G; Gustavsson A; Lundgren G; Lönnqvist B; Ringdén O; Wahren B
Bone Marrow Transplant; 1986 Dec; 1(2):185-92. PubMed ID: 2844333
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus infection in cancer patients: prevention and treatment.
Tang IT; Shepp DH
Oncology (Williston Park); 1992 Jul; 6(7):101-6, 109; discussion 109-10. PubMed ID: 1322152
[TBL] [Abstract][Full Text] [Related]
17. [Development of resistance of herpes simplex virus to antivirus drugs in vitro].
Chen ZJ; Liu WG; Song JZ
Yao Xue Xue Bao; 1992; 27(1):10-4. PubMed ID: 1382356
[TBL] [Abstract][Full Text] [Related]
18. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS.
Marks GL; Nolan PE; Erlich KS; Ellis MN
Rev Infect Dis; 1989; 11(3):474-6. PubMed ID: 2546244
[TBL] [Abstract][Full Text] [Related]
19. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
Birch CJ; Tachedjian G; Doherty RR; Hayes K; Gust ID
J Infect Dis; 1990 Sep; 162(3):731-4. PubMed ID: 2167340
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous herpes simplex virus infections.
Arbesfeld DM; Thomas I
Am Fam Physician; 1991 May; 43(5):1655-64. PubMed ID: 1826983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
